Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia Journal Article


Authors: Prudent, V.; Breitbart, W. S.
Article Title: Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia
Abstract: Chimeric antigen receptor T cells are used in the treatment of B-cell leukemias. Common chimeric antigen receptor T-cell toxicities can range from mild flu-like symptoms, such as fever and myalgia, to a more striking neuropsychiatric toxicity that can present as discrete neurological symptoms and delirium. We report here two cases of chimeric antigen receptor T-cell neuropsychiatric toxicity, one who presented as a mild delirium and aphasia that resolved without intervention, and one who presented with delirium, seizures, and respiratory insufficiency requiring intensive treatment. The current literature on the treatment and proposed mechanisms of this clinically challenging chimeric antigen receptor T-cell complication is also presented. Copyright 2017 © Cambridge University Press.
Keywords: neurotoxicity; acute lymphoblastic leukemia; chimeric antigen receptor; cytokine release syndrome
Journal Title: Palliative and Supportive Care
Volume: 15
Issue: 4
ISSN: 1478-9515
Publisher: Cambridge University Press  
Date Published: 2017-08-01
Start Page: 499
End Page: 503
Language: English
DOI: 10.1017/s147895151600095x
PROVIDER: scopus
PMCID: PMC5496800
PUBMED: 28049548
DOI/URL:
Notes: Article -- Export Date: 1 September 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William S Breitbart
    505 Breitbart